Legend Biotech
#2338
Rank
$6.25B
Marketcap
United States
Country
Dr. Ying Huang Ph.D. (CEO & Director)
Ms. Lori A. Macomber CPA (Chief Financial Officer)
Joanne Choi (Sr. Mang. of Investor Relations)
Summary
History
Legend Biotech was founded in 2018 to discover, develop, and bring transformational cell therapies to cancer patients around the world. Legend Biotech has quickly grown from a small start-up to a leading global clinical-stage biopharmaceutical company focused on discovering, developing and commercializing off-the-shelf cell therapies for oncological indications.
Mission
Vision
Key Team
Mr. Marc Harrison (VP & Gen. Counsel)
Deborah Wong (Exec. Director of Strategic Marketing & Corp. Communications)
Ms. Liz Gosen (Sr. VP of Global Technical Operations)
Mr. Steven J. Gavel (Sr. VP of Commercial Devel., US & Europe)
Dr. Yuhong Qiu Ph.D. (Sr. VP of Global Regulatory Affairs)
Mr. Alan Kick (Sr. VP of Global Quality)
Dr. Guowei Fang Ph.D. (Sr. VP & Global Head of Research and Early Devel.)
Recognition and Awards
References
https://en.wikipedia.org/wiki/GenScript_Biotech
https://in.investing.com/equities/legend-biotech-corp
https://finance.yahoo.com/quote/LEGN/profile?p=LEGN
https://www.comparably.com/companies/legend-biotech/mission
https://www.crunchbase.com/organization/legend-biotech
https://sec.report/CIK/0001801198
Dr. Ying Huang Ph.D. (CEO & Director)
Ms. Lori A. Macomber CPA (Chief Financial Officer)
Joanne Choi (Sr. Mang. of Investor Relations)